Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: J Control Release. 2023 Nov 2;364:312–325. doi: 10.1016/j.jconrel.2023.10.038

Figure 2: VEGF-A and Angiogenin secretion into cellular media after recipient cell’s exposure to Mp.

Figure 2:

In vitro exposure of (A) tumor parenchyma (PC3WT) or (B) Endothelial cells and (C) macrophages (THP-1) with Mp for up to 24 hours, measured by protein array. Graphs show the average concentration of VEGF and Angiogenin. N=3 independent experiments for each (2-way ANOVA was used to compare all data, with WT-Mp acting as a control; ****P <0.0001 and *P=0.0472).